Overview

Intravenous Estrogen in Kidney Transplant Study

Status:
Recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
Ischemia perfusion injury (IRI) is a major cause of organ injury during kidney transplantation. Currently there are no treatments for IRI other than dialysis. Preliminary studies in female mice have found protection from IRI when given short term estrogen supplements. This study will look at the effect of intravenous estrogen given peri-operatively to reduce the effect of IRI in female kidney transplant recipients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Pfizer
Treatments:
Estrogens
Estrogens, Conjugated (USP)